You are here
Clinical Trials: Cord Blood
Conditions: Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphoid System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspirate; Drug: Cyclophosphamide; Drug: Cyclosporine; Procedure: Diagnostic Imaging; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Procedure: Multigated Acquisition Scan; Drug: Mycophenolate Mofetil; Other: Survey Administration; Drug: Thiotepa; Radiation: Total-Body Irradiation; Procedure: Umbilical Cord Blood Transplantation
Sponsors: Fred Hutchinson Cancer Center; National Cord Blood Network
Not yet recruiting
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspirate; Drug: Cyclophosphamide; Drug: Cyclosporine; Procedure: Diagnostic Imaging; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Procedure: Multigated Acquisition Scan; Drug: Mycophenolate Mofetil; Other: Survey Administration; Drug: Thiotepa; Radiation: Total-Body Irradiation; Procedure: Umbilical Cord Blood Transplantation
Sponsors: Fred Hutchinson Cancer Center; National Cord Blood Network
Not yet recruiting
Conditions: Refractory Diabetic Foot; Human Cord Blood-derived Mononuclear Cells; Efficacy; Safety; Local Injection
Intervention: Biological: human cord blood-derived mononuclear cells (HCB-MNCs)
Sponsors: The First Affiliated Hospital with Nanjing Medical University; Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Intervention: Biological: human cord blood-derived mononuclear cells (HCB-MNCs)
Sponsors: The First Affiliated Hospital with Nanjing Medical University; Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Conditions: Hematopoietic Stem Cell Transplantation; Malignant Hematological Diseases
Intervention: Procedure: Umbilical Cord Blood Transplantation
Sponsor: The First Affiliated Hospital of Soochow University
Recruiting
Intervention: Procedure: Umbilical Cord Blood Transplantation
Sponsor: The First Affiliated Hospital of Soochow University
Recruiting
Conditions: Acute Myelogenous Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Chronic Myelogenous Leukemia (CML); Myelodysplastic Syndromes (MDS); Myeloproliferative Disorder; Non-Hodgkin's Lymphoma
Interventions: Drug: Conditioning Chemotherapy; Biological: Cord blood graft
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting
Interventions: Drug: Conditioning Chemotherapy; Biological: Cord blood graft
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting
Condition: Umbilical Cord Blood
Interventions: Procedure: Ex-utero cord blood collection; Procedure: In-utero cord blood collection
Sponsor: Institut Universitari Dexeus
Not yet recruiting
Interventions: Procedure: Ex-utero cord blood collection; Procedure: In-utero cord blood collection
Sponsor: Institut Universitari Dexeus
Not yet recruiting
Condition: Bone Marrow Failure Disorders
Interventions: Drug: Cyclosporine A; Biological: Umbilical cord blood & Umbilical cord derived mesenchymal stem cells
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shandong Third Provincial Hospital; Dezhou People's Hospital; Qilu Children's Hospital of Shandong University; The Second Affiliated Hospital of Shandong First Medical University; Tai'an Central Hospital; Linyi People's Hospital; Linyi Central Hospital; Rizhao People's Hospital; Lanling People's Hospital; Shandong Jining No.1 People's Hospital; The affiliated hospital of Jining medical college; Zibo municipal hospital; Binzhou People's Hospital; The Affiliated Hospital of Binzhou Medical College; Shengli Oilfield Central Hospital; Weihai Municipal Hospital; Weihai Central Hospital; The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine; Gansu Provincial Hospital of Traditional Chinese Medicine (TCM); Wuwei People's Hospital; Gansu Wuwei Tumour Hospital; The Second Affiliated Hospital of Harbin Medical University; Yuncheng Institute of Hematology; Kaifeng Central Hospital; Zhengzhou Central Hospital; Air Force Hospital of Western War Zone; The First People' s Hospital of Yunnan Province; Zigong No.1 Peoples Hospital; The First People's Hospital of Jingzhou; Jiangxi Province Children's Hospital
Not yet recruiting
Interventions: Drug: Cyclosporine A; Biological: Umbilical cord blood & Umbilical cord derived mesenchymal stem cells
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shandong Third Provincial Hospital; Dezhou People's Hospital; Qilu Children's Hospital of Shandong University; The Second Affiliated Hospital of Shandong First Medical University; Tai'an Central Hospital; Linyi People's Hospital; Linyi Central Hospital; Rizhao People's Hospital; Lanling People's Hospital; Shandong Jining No.1 People's Hospital; The affiliated hospital of Jining medical college; Zibo municipal hospital; Binzhou People's Hospital; The Affiliated Hospital of Binzhou Medical College; Shengli Oilfield Central Hospital; Weihai Municipal Hospital; Weihai Central Hospital; The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine; Gansu Provincial Hospital of Traditional Chinese Medicine (TCM); Wuwei People's Hospital; Gansu Wuwei Tumour Hospital; The Second Affiliated Hospital of Harbin Medical University; Yuncheng Institute of Hematology; Kaifeng Central Hospital; Zhengzhou Central Hospital; Air Force Hospital of Western War Zone; The First People' s Hospital of Yunnan Province; Zigong No.1 Peoples Hospital; The First People's Hospital of Jingzhou; Jiangxi Province Children's Hospital
Not yet recruiting
Condition: Graft Vs Host Disease
Intervention: Drug: Cyclophosphamide
Sponsor: Centro de Hematología y Medicina Interna
Enrolling by invitation
Intervention: Drug: Cyclophosphamide
Sponsor: Centro de Hematología y Medicina Interna
Enrolling by invitation
Conditions: Bone Marrow Transplant; Stem Cell Transplant
Intervention: Drug: Zoster Vaccine Recombinant
Sponsors: University of Colorado, Denver; GlaxoSmithKline
Not yet recruiting
Intervention: Drug: Zoster Vaccine Recombinant
Sponsors: University of Colorado, Denver; GlaxoSmithKline
Not yet recruiting
Condition: Spinal Cord Injury, Acute
Interventions: Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells; Other: Control vehicle (sterile saline)
Sponsors: Sklifosovsky Institute of Emergency Care; State-Financed Health Facility "Samara Regional Medical Center Dinasty"; K.L. Hetagurov North-Osetian State University
Recruiting
Interventions: Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells; Other: Control vehicle (sterile saline)
Sponsors: Sklifosovsky Institute of Emergency Care; State-Financed Health Facility "Samara Regional Medical Center Dinasty"; K.L. Hetagurov North-Osetian State University
Recruiting
Condition: Poor Graft Function
Interventions: Drug: decitabine; Biological: umbilical cord blood; Drug: Granulocyte-colony stimulating factor; Drug: Recombinant human thrombopoietin / thrombopoietin receptor agonist; Drug: Recombinant human erythropoietin
Sponsor: The First Affiliated Hospital of Soochow University
Not yet recruiting
Interventions: Drug: decitabine; Biological: umbilical cord blood; Drug: Granulocyte-colony stimulating factor; Drug: Recombinant human thrombopoietin / thrombopoietin receptor agonist; Drug: Recombinant human erythropoietin
Sponsor: The First Affiliated Hospital of Soochow University
Not yet recruiting
2023 AlphaMed Press ©